NASDAQ
Context Therapeutics Inc. (CNTX) has a current ratio of 8.52x as of Monday, May 25, 2026. This represents a 49.97% decrease compared to its 12-month average of 17.04x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.